Current Classification and Management of Inflammatory Myopathies

Area of Science:

• Rheumatology
• Neurology
• Immunology

Background:

• Inflammatory myopathies encompass polymyositis, dermatomyositis, necrotizing myopathy, overlap myositis, and inclusion body myositis.
• These conditions primarily affect middle-aged individuals, presenting with subacute limb weakness, pain, and elevated creatine kinase, except for the chronic course of inclusion body myositis.

Purpose of the Study:

• To provide a comprehensive overview of inflammatory myopathies.
• To detail current classification, diagnostic approaches, treatment strategies, and pathomechanisms.

Main Methods:

• Review of current literature on inflammatory myopathies.
• Analysis of diagnostic criteria including clinical presentation, auto-antibodies, MRI, EMG, and muscle biopsy.

Main Results:

• Polymyositis, dermatomyositis, necrotizing myositis, and overlap myositis generally respond to immunosuppressive therapy.
• Inclusion body myositis is largely refractory to treatment.
• Diagnosis requires a combination of clinical assessment, auto-antibody analysis, and histopathological examination.

Conclusions:

• A multi-faceted diagnostic approach is crucial for accurate myositis classification.
• Treatment response varies significantly among different inflammatory myopathy subtypes.
• Understanding pathomechanisms is key to developing targeted therapies for these debilitating skeletal muscle disorders.